AstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer ...
TOKYO: AstraZeneca Plc and Daiichi Sankyo Co Ltd signed a deal to develop and sell Daiichi's cancer drug trastuzumab deruxtecan that could see the British drugmaker pay as much as US$6.9 billion to its Japanese partner.
Daiichi is the latest Japanese drugmaker to strike such a deal to gain access to a bigger overseas player's R&D and sales clout.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Daiichi Sankyo, AstraZeneca sign US$6.9 billion cancer drug dealAstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer ...
Read more »
US jury says Bayer must pay US$81 million to man in Roundup cancer trialA U.S. jury on Wednesday awarded US$80.9 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his ...
Read more »
US jury says Bayer must pay US$81m to man in Roundup cancer trialA U.S. jury on Wednesday awarded US$80.9 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his ...
Read more »
EU approves AstraZeneca's drug for adjunct use in Type-1 diabetesREUTERS: British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement ...
Read more »
Uber could announce US$3 billion deal with Careem early this week: sourcesUber Technologies Inc is set to offer over US$3 billion to buy Dubai-based rival Careem Networks FZ, two sources familiar with the deal told Reuters.
Read more »
Business chiefs deny US$5 billion fraud over HP-Autonomy dealLONDON: Bosses at a UK software firm, Autonomy, have denied committing fraud to inflate its value before selling the group to US tech giant ...
Read more »
UPS eyes in-home health services with US vaccine projectUnited Parcel Service Inc wants to get beyond U.S. doorsteps with a new push into healthcare.
Read more »
HSA recalls three brands of high blood pressure drug losartan over cancer riskSINGAPORE - Three brands of a medicine prescribed for high blood pressure are being recalled because they contain higher than acceptable amounts of nitrosamine impurity, which can potentially cause cancer.. Read more at straitstimes.com.
Read more »
HSA recalls 3 brands of high blood pressure drug over cancer riskSingapore — The Health Sciences Authority (HSA) has recalled three brands of high blood pressure medicines that contain the ingredient losartan as the drugs contain higher than acceptable levels of a potentially harmful impurity, said the authority on Thursday (March 28).
Read more »
Uber buys rival Careem in $3.1 billion deal to dominate ride-hailing in Middle EastSAN FRANCISCO/DUBAI (Reuters) - Global ride-hailing firm Uber Technologies Inc will spend $3.1 billion to acquire Middle East rival Careem, buying dominance in a competitive region ahead of a hotly anticipated initial public offering. Uber said late on Monday night it would pay $1.4 billion in cash
Read more »